Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research (AACR) 2021 Virtual Annual Meeting Apr 10, 2021 8:30am EDT
Kezar Life Sciences Reports Fourth Quarter and Year End 2020 Financial Results and Provides Business Updates Mar 11, 2021 4:01pm EST
Kezar Life Sciences to Participate at Cowen 41st Annual Virtual Health Care Conference Feb 25, 2021 4:01pm EST
Kezar Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference Jan 07, 2021 4:02pm EST
Kezar Life Sciences Reports Third-Quarter 2020 Financial Results and Provides Business Updates Nov 05, 2020 4:01pm EST
Kezar Highlights Broad Therapeutic Potential of KZR-616 During ACR Convergence 2020 Nov 05, 2020 8:46am EST
Kezar Life Sciences Announces Orphan Drug Designations for KZR-616 for the Treatment of Polymyositis and Dermatomyositis Oct 23, 2020 7:00am EDT
